Updates
Cannabis Use Appears to Encourage, Not Replace, Non-medical Opioid Use
People in the U.S. may not be substituting cannabis for opioids contrary to some claims, according to new research at Columbia University Mailman School of Public Health. The research, published in the scientific journal Addiction, examined the direction and strength...
Study: Americans 30+ Drinking More During COVID-19
New research reported in the journal JAMA Network Open shows Americans over 30 have been drinking more during the coronavirus pandemic compared to this time last year and there could be consequences to their physical and mental health. Researchers also report overall...
New NC Statewide Overdose Surveillance Reports for September 2020
The Injury and Violence Prevention Branch of the Division of Public Health recently updated the provisional data on opioid-related overdose and unintentional med/drug overdose with potential for abuse emergency department visits report (NC DETECT). Overdose Involving...
Concern Over Future of Waivers for Treatment of Opioid Addiction During Pandemic
COVID-19 catalyzed a major shift to telehealth as a result of stay-at-home orders and efforts to prevent infection and disease spread. Regulatory agencies made changes that allowed for more telehealth-friendly clinical interventions which not only provided continued...
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes
Considering increasing cannabis use among pregnant women, the US Surgeon General recently issued an advisory against the use of marijuana during pregnancy. In this cross-sectional analysis of nearly 12,000 children, researchers found that prenatal cannabis exposure...
Syringe Services Struggling to Provide Care Amid COVID-19
Americans who struggle with drug addiction have been using syringe services programs (SSPs) for decades – not only to exchange used needles for clean ones but also as a first step towards treatment. Avoiding reusing needles reduces the risk of contracting infectious...
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Thank you for your time and commitment to preventing drug overdose in North Carolina. We hope that you will be able to join us at our next meeting of the NC Department of Health and Human Services Opioid and Prescription Drug Abuse Advisory Committee (NC DHHS OPDAAC) on Friday, December 11, 2020. This meeting’s focus will be on Justice-involved Populations.
The agenda will be shared closer to the meeting date.
Please note that the virtual meeting information can be found in your confirmation email.
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Target Audience
Sessions 1-3: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams.
Sessions 4-6: Physicians, nurse practitioners or other advanced practice nurses, PAs, and healthcare teams.
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.